Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 5/20 | 0.50 |
| ▸ | MAPT | P10636 | 3/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.50 |
| ▸ | HPGD | P15428 | 1/20 | 0.48 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.48 |
| ▸ | MAOB | P27338 | 4/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.47 |
| ▸ | NPC1 | O15118 | 1/20 | 0.44 |
| ▸ | DRD2 | P14416 | 1/20 | 0.44 |
| ▸ | DRD3 | P35462 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | PRKDC | P78527 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23966170 | 0.76 | CARM1 (0.37) | — | |
| SCHEMBL12227464 | 0.75 | HPGD (0.82) | RAB9AMAPTL3MBTL1SMN1; SMN2HPGD | |
| SCHEMBL23966192 | 0.75 | L3MBTL1 (0.34) | RAB9AL3MBTL1HPGDNPSR1MAOB | |
| SCHEMBL10527876 | 0.74 | RAB9A (0.61) | RAB9AMAPTL3MBTL1SMN1; SMN2HPGD | |
| SCHEMBL23742932 | 0.74 | RAB9A (0.61) | RAB9AMAPTL3MBTL1SMN1; SMN2HPGD | |
| SCHEMBL30105286 | 0.74 | RAB9A (0.61) | RAB9AMAPTL3MBTL1SMN1; SMN2HPGD | |
| SCHEMBL18501643 | 0.73 | RAB9A (0.83) | RAB9AMAPTSMN1; SMN2HPGDNPSR1 | |
| SCHEMBL10680921 | 0.73 | HPGD (0.58) | RAB9AMAPTL3MBTL1SMN1; SMN2HPGD | |
| SCHEMBL7530393 | 0.73 | RAB9A (0.60) | RAB9AMAPTL3MBTL1SMN1; SMN2HPGD | |
| SCHEMBL1999435 | 0.73 | RAB9A (0.90) | RAB9AMAPTL3MBTL1SMN1; SMN2HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210356461-A1 | CARBENE COMPOUND, CARBENE-METAL NANOPARTICLE COMPLEX AND PREPARATION METHOD THEREOF | KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY (KR) | 2021-11-18 | — | — | US | disclosed |
| US-20210229104-A1 | SUBSTRATE FOR NUCLEIC ACID AMPLIFICATION, AND METHOD FOR MANUFACTURING SAME | KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY (KR) | 2021-07-29 | — | — | US | disclosed |
| WO-2020138982-A1 | GRAPHENE CHANNEL MEMBER COMPRISING CADAVERINE OLFACTORY RECEPTOR AND SENSOR COMPRISING SAME | 한국생명공학연구원 | 2020-07-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210356461-A1 | CARBENE COMPOUND, CARBENE-METAL NANOPARTICLE COMPLEX AND PREPARATION METHOD THEREOF | MB, CLTB, PARN | RAB9A 806/4885MAPT 2416/4885L3MBTL1 1619/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.